Sonnet BioTherapeutics Holdings Inc (SONN)
1.81
+0.11
(+6.47%)
USD |
NASDAQ |
May 13, 16:00
1.81
0.00 (0.00%)
After-Hours: 20:00
Sonnet BioTherapeutics Holdings Profit Margin (Quarterly): -6.27K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -6.27K% |
| September 30, 2023 | -9.87K% |
| June 30, 2023 | -10.71K% |
| March 31, 2023 | -15.55K% |
| December 31, 2022 | -14.88K% |
| September 30, 2022 | -11.85K% |
| June 30, 2022 | -12.69K% |
| March 31, 2022 | -8.61K% |
| Date | Value |
|---|---|
| December 31, 2021 | -4.78K% |
| September 30, 2021 | -1.44K% |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | -33.82% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-15.55K%
Minimum
Mar 2023
-33.82%
Maximum
Mar 2020
-8.79K%
Average
-9.87K%
Median
Sep 2023
Profit Margin (Quarterly) Benchmarks
| ACADIA Pharmaceuticals Inc | 8.04% |
| Ainos Inc | -29.77K% |
| CytomX Therapeutics Inc | 33.26% |
| Amylyx Pharmaceuticals Inc | -134.0% |
| CERo Therapeutics Holdings Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -951.7% |
| Return on Assets | -185.1% |
| Return on Invested Capital | -951.5% |
| Operating Margin (Quarterly) | -6.87K% |
| Return on Net Operating Assets | -239.8% |